Literature DB >> 32003702

Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years.

Hongyu Tao1, Ling Zuo2, Huanli Xu1, Cong Li1, Gan Qiao2, Mingyue Guo2, Xiukun Lin2.   

Abstract

BACKGROUND: In recent years, many novel alkaloids with anticancer activity have been found in China, and some of them are promising for developing as anticancer agents.
OBJECTIVE: This review aims to provide a comprehensive overview of the information about alkaloid anticancer agents disclosed in Chinese patents, and discusses their potential to be developed as anticancer drugs used clinically.
METHODS: Anticancer alkaloids disclosed in Chinese patents in recent 5 years were presented according to their mode of actions. Their study results published on PubMed, and SciDirect databases were presented.
RESULTS: More than one hundred anticancer alkaloids were disclosed in Chinese patents and their mode of action referred to arresting cell cycle, inhibiting protein kinases, affecting DNA synthesis and p53 expression, etc.
Conclusion: Many newly found alkaloids displayed potent anticancer activity both in vitro and in vivo, and some of the anticancer alkaloids acted as protein kinase inhibitors or CDK inhibitors possess the potential for developing as novel anticancer agents. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Alkaloids; DNA damage; anticancer; cell circle arrest; p53 expression; protein kinase inhibitor.

Year:  2020        PMID: 32003702     DOI: 10.2174/1574892815666200131120618

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  2 in total

Review 1.  Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products.

Authors:  Xin Su; Mingyang Zhou; Yingjian Li; Na An; Fan Yang; Guoxia Zhang; Lianjiang Xu; Hengwen Chen; Hongjin Wu; Yanwei Xing
Journal:  Oxid Med Cell Longev       Date:  2022-05-16       Impact factor: 7.310

2.  Overexpression of ABCC1 Confers Drug Resistance to Betulin.

Authors:  Xuan-Yu Chen; Yuqi Yang; Jing-Quan Wang; Zhuo-Xun Wu; Jing Li; Zhe-Sheng Chen
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.